M. Hoffmann - Concepedia

Author

M. Hoffmann

Medical University of Vienna

Also Known As

Amanda Razera, M Hoffmann, M. Hoffmann, MFC Hoffmann, Matheus Hoffmann

Publications

895

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna University of Vienna European Association of Nuclear Medicine

About

M. Hoffmann is an author at Medical University of Vienna specializing in medicine, pathology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	622
2	Health Sciences	5	5	389
3	Nursing	1	1	32
4	Diabetes	1	1	22
5	Endocrinology	1	1	22

M. Hoffmann

Publications

868

Citations

H-Index

Page 1

	Year	Citations
Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type M. Hoffmann, Kurt Kletter, Markus Diemling, Annals of Oncology Positron Emission TomographyLymphoid NeoplasiaSurgical PathologyHistopathologyImmunology	1999	166
18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading Stefan Wöhrer, Ulrich Jaeger, Kurt Kletter, Annals of Oncology Positron Emission TomographyLymphoid NeoplasiaOncologic ImagingMedical ImagingPet-mri	2006	121
MALT lymphoma in patients with autoimmune diseases: a comparative analysis of characteristics and clinical course Stefan Wöhrer, Marlene Troch, Berthold Streubel, Leukemia Primary ImmunodeficiencyLymphoid NeoplasiaAutoimmune DiseaseImmunodeficienciesImmunology	2007	98
18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma M. Hoffmann Gut	2003	92
18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference M. Hoffmann, Stefan Wöhrer, Alexander Becherer, Annals of Oncology	2006	77
Bortezomib combined with rituximab and dexamethasone is an active regimen for patients with relapsed and chemotherapy-refractory mantle cell lymphoma Wolfgang Lamm, H. Kaufmann, Markus Raderer, Haematologica	2011	77
Chronic autoimmune thyroiditis (Hashimoto's thyroiditis) in patients with MALT lymphoma Marlene Troch, Stefan Woehrer, Berthold Streubel, Annals of Oncology Autoimmune DiseaseThyroid DiseaseThyroid DisordersMalt LymphomaAutoimmunity	2008	52
Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma Stefan Wöhrer, Andreas Chott, Johannes Drach, Annals of Oncology Lymphoid NeoplasiaSurgical OncologyMedicineImmunologyPathology	2004	50
Six versus eight cycles of biweekly CHOP-14 with or without R in elderly patients (pts) with aggressive CD20<sup>+</sup> B-cell lymphomas: Seven-year FU of the RICOVER-60 trial of the DSHNHL. Michael Pfreundschuh, Marita Ziepert, Samira Zeynalova, Journal of Clinical Oncology Lymphoid NeoplasiaClinical EffectivenessGeriatricsMedicineElderly Patients	2011	48
Pathology and clinical course of MALT lymphoma with plasmacytic differentiation Stefan Wöhrer, Marlene Troch, Berthold Streubel, Annals of Oncology Lymphoid NeoplasiaSurgical PathologyHematologyPathologyMalt Lymphoma	2007	33

Page 1